Investors Research Corp’s Eli Lilly LLY Stock Holding History

Investors Research Corp’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-6	Closed	-$3.5K	–	1067
2023 Q4	$3.5K	Buy	+6	New	+$3.5K	﹤0.01%	884
2023 Q2	–	Sell	-1,780	Closed	-$611K	–	1107
2023 Q1	$611K	Hold	1,780	–	–	0.16%	171
2022 Q4	$651K	Hold	1,780	–	–	0.18%	164
2022 Q3	$576K	Hold	1,780	–	–	0.18%	161
2022 Q2	$577K	Sell	1,780 -100	-5%	-$30K	0.17%	173
2022 Q1	$538K	Buy	1,880 +16	+0.9%	+$4.12K	0.15%	185
2021 Q4	$515K	Hold	1,864	–	–	0.16%	175
2021 Q3	$431K	Hold	1,864	–	–	0.15%	193
2021 Q2	$428K	Buy	1,864 +100	+6%	+$20.1K	0.15%	193
2021 Q1	$330K	Hold	1,764	–	–	0.12%	228
2020 Q4	$298K	Hold	1,764	–	–	0.12%	243
2020 Q3	$261K	Hold	1,764	–	–	0.13%	239
2020 Q2	$290K	Hold	1,764	–	–	0.15%	210
2020 Q1	$245K	Hold	1,764	–	–	0.15%	218
2019 Q4	$232K	Hold	1,764	–	–	0.11%	263
2019 Q3	$197K	Buy	1,764 +93	+6%	+$10.4K	0.1%	266
2019 Q2	$185K	Hold	1,671	–	–	0.1%	267
2019 Q1	$217K	Buy	+1,671	New	+$203K	0.12%	242

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Investors Research Corp's LLY Position: Q1 2024 in Review

Investors Research Corp sold out of Eli Lilly (LLY) in Q1 2024, closing a stake of 6 shares — an estimated $3.5K sold.

Investors Research Corp first reported a position in LLY in Q1 2019 and held it in 18 quarters. The position peaked at $651K in Q4 2022. 3,460 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

Investors Research Corp reported no remaining Eli Lilly position as of Q1 2024 after selling out during the quarter.
Investors Research Corp sold 6 Eli Lilly shares in Q1 2024, an estimated $3.5K.
Investors Research Corp first reported a position in Eli Lilly in Q1 2019 and held it in 18 quarters.
Investors Research Corp's Eli Lilly position peaked at $651K in Q4 2022.
3,460 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on Investors Research Corp's 13F filing for Q1 2024, filed 6 May 2024.